Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating costs and expenses
General and administrative	$ 734	$ 892	$ 3,054	$ 2,483
Research and development	191		951	10
Research and development - license acquired	41	10	1,154	10
Total operating expenses	966	902	5,159	2,503
Loss from operations	(966)	(902)	(5,159)	(2,503)
Other income (expenses)
Other income	4		19
Gains and (losses) on marketable securities	(433)	(33)	(171)	31
Change in fair value of investment	(622)	(2,435)	(7,352)	(2,765)
Change in fair value of warrant liabilities		7		81
Total other expenses	(1,051)	(2,461)	(7,504)	(2,653)
Net loss	$ (2,017)	$ (3,363)	$ (12,663)	$ (5,156)
Net loss per share, basic and diluted
Basic and Diluted	$ (0.06)	$ (1.38)	$ (0.49)	$ (2.35)
Weighted average number of shares outstanding, basic and diluted
Basic and Diluted	34,986,885	2,442,243	25,753,040	2,193,883